Article
Homologous recombination deficiency in pancreatic neuroendocrine tumors.
Future oncology (London, England) - 1 Dec 2024
Bardasi Camilla, Tenedini Elena, Bonamici Lia, Benatti Stefania, Bonetti Luca Reggiani, Luppi Gabriele, Cortesi Laura, Tagliafico Enrico, Dominici Massimo, Gelsomino Fabio
Abstract excerpt
Aim: Pancreatic Neuroendocrine tumors (pNETs) are a heterogeneous group of neoplasms whose tumor biology is still little known. Thanks to next-generation sequencing, pathogenic mutations in base-excision-repair MUTYH gene and homologous recombination genes CHEK2 and BRCA2 seem to have a role in the development of pNETs.Research design & methods: We assumed that Homologous Recombination Deficiency (HRD) could be a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
